A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C
Karen L. Lindsay, Christian Trepo, Tobias Heintges, Mitchell L. Shiffman, Stuart C. Gordon, John C. Hoefs, Eugene R. Schiff, Zachary D. Goodman, Mark Laughlin, Ruji Yao, Janice K. AlbrechtVolume:
34
Year:
2001
Language:
english
Pages:
9
DOI:
10.1053/jhep.2001.26371
File:
PDF, 149 KB
english, 2001